Antidepressants during pregnancy increase the risk of obesity and diabetes in children

    




Women who take antidepressants during pregnancy, increases the risk of obesity and diabetes in future children.

A study at McMaster University showed a correlation between the use of fluoxetine during pregnancy and an increased risk of obesity and diabetes in children. Author Allison Holloway said: "Our study showed that the use of the mother antidepressants may be a factor contributing to obesity and diabetes."

"The results of the experiment do not suggest that women should avoid taking antidepressants during pregnancy, but there may be risks associated with their admission, which was not previously defined," says Holloway. "The advantage of this study is that it can help identify groups of children at high risk who may require specific measures for preventing obesity and diabetes type 2 later in life," says the scientist.

The next stage of the study will be the understanding why these drugs are dangerous. "If we can understand how the antidepressant causes adverse metabolic outcomes in the offspring, we can design therapeutic strategies to prevent damage by allowing women who require these drugs to be treated without causing potential harm to the offspring."

Source: nauka24news.ru/